{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-028384","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.346358+00:00","generated_at":"2026-06-11T23:06:19.737834+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GoodRx Q2 revenue $189.7M beats guidance; Adj. EBITDA $53.5M","bullets":["Total revenue $189.7M, exceeding previously announced guidance; net income $58.8M (includes $46.7M tax benefit).","Adjusted EBITDA $53.5M (28.2% margin), also above guidance; adjusted net income $28.4M.","Prescription transactions revenue and volume returned to year-over-year growth.","Over 500,000 prescribers engaged via Provider Mode; over 7M consumers of prescription offerings.","New program with CVS Caremark and expanded direct pharmacy contracts."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-028384","json":"https://secwatch.observer/filing/0001628280-23-028384.json","markdown":"https://secwatch.observer/filing/0001628280-23-028384.md","text":"https://secwatch.observer/filing/0001628280-23-028384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000162828023028384/0001628280-23-028384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000162828023028384/gdrx-20230809.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T23:06:19.737834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f5af65f921dcc74deec83cd8e3688fd61630b794","claim":"GoodRx Holdings, Inc. reported the three and six months ended June 30, 2023 results: revenue $189.7 million, net income $58.8 million.","evidence_excerpt":"Total revenue of $189.7 million, exceeding previously announced guidance • Net income of $58.8 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000162828023028384/0001628280-23-028384-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Revenue","value":"$189.7 million"},{"label":"Net income","value":"$58.8 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}